Education
About Us
Working with TipRanks
Follow Us
BB Biotech (0JYO) (CH:BION)
:BION
BION Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF34.45 - CHF49.20
Previous CloseN/A
Volume20.47K
Average Volume (3M)N/A
Market Cap
CHF1.89B
Enterprise ValueN/A
Total Cash (Recent Filing)CHF405.00K
Total Debt (Recent Filing)CHF344.70M
Price to Earnings (P/E)25.7
Beta0.84
Next Earnings
Apr 25, 2025EPS EstimateN/A
Next Dividend Ex-Date
Mar 21, 2025Dividend Yield5.61%
Share Statistics
EPS (TTM)1.39
Shares Outstanding55,400,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF66.00Price Target Upside85.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
<0.01% Mutual Funds
― Other Institutional Investors
99.39% Public Companies and
Individual Investors
BION FAQ
What was BB Biotech (0JYO)’s price range in the past 12 months?
BB Biotech (0JYO) lowest stock price was CHF34.45 and its highest was CHF49.20 in the past 12 months.
What is BB Biotech (0JYO)’s market cap?
BB Biotech (0JYO)’s market cap is CHF1.89B.
When is BB Biotech (0JYO)’s upcoming earnings report date?
BB Biotech (0JYO)’s upcoming earnings report date is Apr 25, 2025 which is in 43 days.
How were BB Biotech (0JYO)’s earnings last quarter?
BB Biotech (0JYO) released its earnings results on Jan 24, 2025. The company reported CHF1.089 earnings per share for the quarter, beating the consensus estimate of N/A by CHF1.089.
Is BB Biotech (0JYO) overvalued?
According to Wall Street analysts BB Biotech (0JYO)’s price is currently Undervalued.
Does BB Biotech (0JYO) pay dividends?
BB Biotech (0JYO) pays a Annually dividend of CHF2 which represents an annual dividend yield of 5.61%. See more information on BB Biotech (0JYO) dividends here
What is BB Biotech (0JYO)’s EPS estimate?
BB Biotech (0JYO)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BB Biotech (0JYO) have?
BB Biotech (0JYO) has 55,400,000 shares outstanding.
What happened to BB Biotech (0JYO)’s price movement after its last earnings report?
BB Biotech (0JYO) reported an EPS of CHF1.089 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.255%.
Which hedge fund is a major shareholder of BB Biotech (0JYO)?
Currently, no hedge funds are holding shares in CH:BION
---
Company Description
BB Biotech (0JYO)
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the health care system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace.
---
BION Stock 12 Month Forecast
Average Price Target
CHF66.00
▲(85.39% Upside)
Best Analysts Covering BION
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-7.43%
reiterated a buy rating 3 days ago
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.43% per trade.
---